How does Edluar compare to Ambien for treating insomnia. What are the key differences between sublingual and oral zolpidem formulations. Which medication shows better results for sleep induction and overall sleep quality.

Overview of Edluar and Ambien for Insomnia

Edluar and Ambien are both brand names for the drug zolpidem, which is commonly prescribed to treat insomnia. While they contain the same active ingredient, there are some key differences between these two medications:

• Edluar is a sublingual tablet that dissolves under the tongue
• Ambien is an oral tablet that is swallowed
• Edluar may work faster due to its sublingual delivery method
• Ambien is available as immediate-release and extended-release formulations

Understanding these differences can help patients and healthcare providers determine which formulation may be most appropriate for an individual’s insomnia symptoms and treatment needs.

Patient Reviews and Ratings of Edluar

According to user reviews on Drugs.com, Edluar has received largely positive feedback from patients using it to treat insomnia:

• Average rating of 9.2 out of 10 based on 12 reviews
• 92% of reviewers reported a positive experience
• 0% reported a negative experience
• 58% gave it a perfect 10/10 rating

These high ratings suggest that many patients find Edluar to be an effective treatment for their insomnia symptoms. However, it’s important to note that individual experiences can vary, and a larger sample size would provide more comprehensive data.

Comparing Effectiveness: Edluar vs Ambien

A randomized, double-blind study compared the hypnotic effects of sublingual zolpidem (Edluar) 10 mg to oral zolpidem (Ambien) 10 mg in patients with primary insomnia. The study found several key differences in effectiveness:

• Edluar shortened latency to persistent sleep (LPS) by 34% or 10.3 minutes compared to Ambien
• Edluar showed faster sleep induction, measured by sleep onset latency (SOL) and latency to stage 1 sleep (ST1L)
• Both formulations demonstrated similar effects on total sleep time and sleep efficiency

These results suggest that the sublingual formulation of Edluar may offer advantages in terms of faster sleep onset compared to the oral formulation of Ambien.

Mechanism of Action: How Edluar Works

Edluar, like other zolpidem formulations, works by enhancing the effects of GABA (gamma-aminobutyric acid) in the brain. GABA is a neurotransmitter that promotes relaxation and sleep. Here’s how Edluar specifically affects sleep:

• Binds to GABA-A receptors in the brain
• Increases the inhibitory effects of GABA
• Reduces brain activity and promotes drowsiness
• Sublingual delivery allows for faster absorption into the bloodstream

The sublingual formulation of Edluar is designed to dissolve quickly under the tongue, potentially leading to faster onset of action compared to oral tablets that must be digested before absorption.

Dosage and Administration Guidelines for Edluar

Proper dosage and administration of Edluar are crucial for its effectiveness and safety. Here are some key guidelines:

• Standard dose is 5 mg for women and 5 or 10 mg for men
• Take immediately before bedtime
• Allow the tablet to dissolve completely under the tongue
• Do not swallow or take with water
• Only take when you have 7-8 hours available for sleep

It’s important to follow your healthcare provider’s instructions and not exceed the recommended dose. Taking Edluar with less than 7-8 hours of sleep time remaining may increase the risk of next-day impairment.

Potential Side Effects and Safety Considerations

While Edluar can be an effective treatment for insomnia, it’s important to be aware of potential side effects and safety considerations:

• Drowsiness and dizziness, especially the morning after use
• Headache and nausea
• Potential for complex sleep behaviors (e.g., sleep-walking, sleep-driving)
• Risk of dependence and withdrawal symptoms with long-term use
• Interactions with alcohol and other CNS depressants

Patients should discuss any concerns or unusual symptoms with their healthcare provider. It’s also important to avoid activities requiring full alertness until you know how Edluar affects you.

Long-term Use and Alternatives to Edluar

While Edluar can be effective for short-term insomnia treatment, long-term use of sleep medications is generally not recommended. Here are some considerations for ongoing insomnia management:

• Cognitive Behavioral Therapy for Insomnia (CBT-I) as a first-line treatment
• Sleep hygiene improvements and lifestyle changes
• Exploring underlying causes of insomnia (e.g., stress, medical conditions)
• Alternative medications or natural remedies under medical supervision

If insomnia persists beyond a few weeks, it’s important to consult with a healthcare provider to develop a comprehensive treatment plan that addresses the root causes of sleep difficulties.

Non-Pharmacological Approaches to Insomnia Management

In addition to medications like Edluar, there are several non-pharmacological approaches that can be effective for managing insomnia:

• Establishing a consistent sleep schedule
• Creating a relaxing bedtime routine
• Optimizing the sleep environment (e.g., temperature, darkness, noise level)
• Limiting caffeine and alcohol intake, especially in the evening
• Regular exercise, but not too close to bedtime
• Stress reduction techniques such as meditation or deep breathing exercises

Many sleep experts recommend trying these approaches before or in conjunction with sleep medications to promote sustainable improvements in sleep quality.

Comparing Edluar to Other Insomnia Medications

While Edluar has shown effectiveness for many patients, it’s not the only option for treating insomnia. Here’s how it compares to some other common sleep medications:

• Ambien CR: Extended-release formulation for longer-lasting effects
• Lunesta (eszopiclone): May have a lower risk of next-day impairment
• Sonata (zaleplon): Shorter half-life, potentially fewer morning-after effects
• Belsomra (suvorexant): Works on a different mechanism (orexin receptor antagonist)
• Rozerem (ramelteon): Targets melatonin receptors, may have lower abuse potential

The choice of medication depends on individual factors such as the specific type of insomnia, medical history, and potential drug interactions. A healthcare provider can help determine the most appropriate option.

Patient Experiences and Testimonials

While clinical studies provide important data on Edluar’s effectiveness, patient experiences can offer valuable insights into real-world use. Here are some common themes from user reviews:

• “Edluar helps me fall asleep much faster than other sleep aids I’ve tried.”
• “I appreciate not having to swallow a pill, especially when I’m already drowsy.”
• “The effects seem to wear off by morning, so I don’t feel groggy when I wake up.”
• “It’s been effective for my occasional insomnia, but I try not to use it too often.”

These testimonials highlight the potential benefits of Edluar, but it’s important to remember that individual experiences can vary. Always consult with a healthcare provider to determine if Edluar is appropriate for your specific situation.

Addressing Common Concerns About Edluar

Patients considering Edluar often have questions about its use and potential risks. Here are some common concerns and their explanations:

1. Is Edluar addictive?

   While Edluar has a low potential for addiction when used as prescribed, there is a risk of dependence with long-term use. It’s important to follow your doctor’s instructions and not use the medication for longer than recommended.

   

2. Can I drive the morning after taking Edluar?

   It’s generally advised to avoid driving or operating heavy machinery the morning after taking Edluar until you know how it affects you. Some people may experience lingering drowsiness or impaired reaction times.

3. Are there any dietary restrictions with Edluar?

   Edluar should be taken on an empty stomach for optimal absorption. Avoid taking it with or immediately after a meal, as this can delay its effects.

4. What should I do if I miss a dose?

   If you miss a dose of Edluar, only take it if you still have 7-8 hours available for sleep. Otherwise, skip the missed dose and resume your regular dosing schedule the next night.

Always consult your healthcare provider or pharmacist if you have specific questions or concerns about using Edluar.

Future Developments in Insomnia Treatment

As research into sleep disorders continues, new treatments for insomnia are being developed. Some areas of ongoing investigation include:

• Novel drug targets that may offer more selective effects on sleep circuits
• Personalized medicine approaches based on genetic or biomarker profiles
• Advanced sleep monitoring technologies for more precise diagnosis and treatment
• Combination therapies that integrate pharmacological and non-pharmacological approaches
• Digital therapeutics and mobile apps for cognitive behavioral therapy delivery

While Edluar and similar medications remain important tools for managing insomnia, future developments may offer even more targeted and effective treatment options.

Conclusion and Key Takeaways

Edluar offers a sublingual formulation of zolpidem that has shown effectiveness in treating insomnia, particularly in terms of reducing sleep onset time. Key points to remember include:

• Edluar dissolves under the tongue, potentially leading to faster absorption and onset of action compared to oral formulations like Ambien
• Patient reviews indicate high satisfaction rates, with an average rating of 9.2/10 on Drugs.com
• Clinical studies have demonstrated Edluar’s effectiveness in reducing time to fall asleep
• Proper dosage and administration are crucial for safety and efficacy
• As with all sleep medications, Edluar should be used under medical supervision and in conjunction with good sleep hygiene practices
• Long-term management of insomnia often requires a multi-faceted approach, including non-pharmacological strategies

If you’re struggling with insomnia, consult with a healthcare provider to determine if Edluar or another treatment approach might be right for you. Remember that effective insomnia management often involves addressing underlying causes and developing sustainable sleep habits in addition to any medication use.

Edluar for Insomnia Reviews – Drugs.com

Print

Save

Edluar
has an average rating of 9.2 out of 10 from a total of 12 reviews
for the
treatment of Insomnia.
92% of reviewers reported a positive experience, while 0% reported a negative experience.

Edluar rating summary

9.2/10 average rating

12 ratings from 13 user reviews.

Compare all 83 medications used in the treatment of Insomnia.

Reviews for Edluar

Frequently asked questions

• Quviviq vs. Ambien: How do they compare?
• Ambien: What are 11 Things You Need to Know?
• Why am I unable to sleep after taking Ambien?
• Is Ambien safe for long-term use?

Are you taking this medicine?

• Add your review
• Learn more about Edluar

More FAQ

• Is Ambien a benzo?
• Is Ambien addictive?
• What is this pill? Tannish peach color, elliptical, marked 10 MG and 5 dots in a small box?
• What is the half life of Ambien?

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.

Learn more about Insomnia

• Anticholinergic Drugs to Avoid in the Elderly
• Benzodiazepines: Overview and Use
• Sleep (Insomnia) Medications and Alcohol Interactions

Care guides

• Insomnia

Symptoms and treatments

• Insomnia

Medicine.

com guides (external)

• Insomnia Guide

More about Edluar (zolpidem)

• Check interactions
• Compare alternatives
• Pricing & coupons
• Drug images
• Latest FDA alerts (4)
• Side effects
• Dosage information
• During pregnancy
• Generic availability
• FDA approval history
• Drug class: miscellaneous anxiolytics, sedatives and hypnotics
• Breastfeeding
• En español

Patient resources

• Drug Information

Other brands

Ambien, Ambien CR, Zolpimist, Intermezzo

Professional resources

• Prescribing Information

Related treatment guides

• Insomnia

Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia

Randomized Controlled Trial

. 2010 Jun;26(6):1423-31.

doi: 10. 1185/03007991003788225.

Corinne Staner 
¹
, Frédéric Joly, Nathalie Jacquot, Irina D Vlasova, Maria Nehlin, Thomas Lundqvist, Charlotte Edenius, Luc Staner

Affiliations

Affiliation

• ¹ Forenap Pharma, Rouffach, France.

• PMID:

  20397964

• DOI:

  10.1185/03007991003788225

Randomized Controlled Trial

Corinne Staner et al.

Curr Med Res Opin.

2010 Jun.

. 2010 Jun;26(6):1423-31.

doi: 10.1185/03007991003788225.

Authors

Corinne Staner 
¹
, Frédéric Joly, Nathalie Jacquot, Irina D Vlasova, Maria Nehlin, Thomas Lundqvist, Charlotte Edenius, Luc Staner

Affiliation

• ¹ Forenap Pharma, Rouffach, France.

• PMID:

  20397964

• DOI:

  10.1185/03007991003788225

Abstract

Objective:

To compare the hypnotic effects of a single dose of a sublingual formulation of zolpidem (Edluar*) 10 mg vs oral formulation (Ambien dagger ) 10 mg by polysomnography (PSG) in DSM-IV primary insomnia patients. Primary objective was to compare the two formulations on sleep induction, measured by latency to persistent sleep (LPS), sleep onset latency (SOL) and latency to stage 1 (ST1L).

Research and methods:

This was a randomized, double-blind, two-period, cross-over multi-centre study in which each period comprised two successive PSG recording nights. Treatment was administered when PSG recordings started. Subjective sleep and residual effects were assessed the next morning.

Results:

Seventy female and male patients aged 19-64 were analysed. Sublingual zolpidem significantly shortened LPS by 34% or 10.3 minutes as compared to oral zolpidem (95% CI: -4.3 min to -16.2 min, p = 0.001). SOL and ST1L were also significantly shortened (p < 0.01). Furthermore the two formulations were comparable in terms of sleep maintenance properties based on total sleep time (TST). The improvement in subjective sleep and next-day residual effects did not differ between the two treatments. Both routes of administration were well tolerated.

Conclusions:

The results demonstrate that sublingual zolpidem is superior to an equivalent dose of oral zolpidem in terms of sleep inducing properties in a carefully selected sample of primary insomnia patients.

Similar articles

• Sublingual zolpidem (Edluar™; Sublinox™).

  Yang LP, Deeks ED.

  Yang LP, et al.
  CNS Drugs. 2012 Nov;26(11):1003-10. doi: 10.1007/s40263-012-0009-y.
  CNS Drugs. 2012.

  PMID: 23034583

  Review.

• Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.

  Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T.

  Staner L, et al.
  Sleep Med. 2009 Jun;10(6):616-20. doi: 10.1016/j.sleep.2008.06.008. Epub 2008 Nov 8.
  Sleep Med. 2009.

  PMID: 18996742

  Clinical Trial.

• Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

  Roth T, Soubrane C, Titeux L, Walsh JK; Zoladult Study Group.

  Roth T, et al.
  Sleep Med. 2006 Aug;7(5):397-406. doi: 10.1016/j.sleep.2006.04.008. Epub 2006 Jul 3.
  Sleep Med. 2006.

  PMID: 16815744

  Clinical Trial.

• Lower doses of sublingual Zolpidem are more effective than oral Zolpidem to anticipate sleep onset in healthy volunteers.

  Valente KD, Hasan R, Tavares SM, Gattaz WF.

  Valente KD, et al.
  Sleep Med. 2013 Jan;14(1):20-3. doi: 10.1016/j.sleep.2012.09.003. Epub 2012 Dec 4.
  Sleep Med. 2013.

  PMID: 23218533

  Clinical Trial.

• A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.

  Staner L, Danjou P, Luthringer R.

  Staner L, et al.
  Expert Rev Neurother. 2012 Feb;12(2):141-53. doi: 10.1586/ern.11.197.
  Expert Rev Neurother. 2012.

  PMID: 22288669

  Review.

See all similar articles

Cited by

• Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial.

  Castro LS, Otuyama LJ, Fumo-Dos-Santos C, Tufik S, Poyares D.

  Castro LS, et al.
  Braz J Psychiatry. 2020 Apr;42(2):175-184. doi: 10.1590/1516-4446-2019-0389. Epub 2019 Dec 20.
  Braz J Psychiatry. 2020.

  PMID: 31859791
  Free PMC article.

  Clinical Trial.

• Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

  Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL.

  Sateia MJ, et al.